GLP-1 weight loss medications have evolved from ~15% weight loss with semaglutide (Wegovy 2.4 mg) to ~20%+ with higher-dose semaglutide (7.2 mg) and dual agonists like tirzepatide (Zepbound). Tirzepatide still shows slightly higher peak results, but high-dose Wegovy significantly narrows the gap, giving clinicians two viable paths to achieve near–bariatric-level weight loss. The Big Shift:
If you’re considering professional support for managing your weight, understanding the medical weight loss consultation process can help you feel more prepared and confident. Unlike general dieting advice, medically supervised weight loss focuses on evaluating your health, lifestyle, and metabolic factors to create a personalized strategy. This article walks through what typically happens before, during,
